-
The main news of the pharmaceutical industry for the 15th week of 2024
Read more: The main news of the pharmaceutical industry for the 15th week of 2024The American supplier of dialysis solutions, Baxter International, has suspended its operations in Russia. The company cited its decision as being due to sanction-related and logistical issues.
-
Money Growth: Pharmaceutical Market Results for 2023
Read more: Money Growth: Pharmaceutical Market Results for 2023In 2023, the Russian pharmaceutical market remained almost at the same level as in 2022, increasing by only 0.3% to 2,578 billion rubles. In dollars and euros, the market noticeably contracted in 2023 due to the weakening of the ruble. In dollar terms, the volume amounted to $30.8 billion, which is 18% lower than the…
-
Stop, giants. Where are the top 200 pharmacy chain participants headed in terms of revenue in 2023?
Read more: Stop, giants. Where are the top 200 pharmacy chain participants headed in terms of revenue in 2023?A dull story The announcement of the sale of Andrei Godovalov’s house in Perm has been removed from publication on Avito. Foam blocks with a facing of solid brick on the outside, calm (though not without designer sophistication) interiors inside. A canopy for several cars, a romantic bench under apple trees gaining strength, a playground…
-
A sub-commission has been established on the use of patents to ensure the economic security of the state.
Read more: A sub-commission has been established on the use of patents to ensure the economic security of the state.The mechanism being developed optimizes the application of the Civil Code provision. Thus, the sub-commission will operate on a “one-stop shop” principle for Russian companies to which foreign patent holders have unjustifiably denied the right to use inventions, utility models, and industrial designs. The resolution also introduces changes to the methodology for determining the amount…
-
Approved action plan for implementing the “Pharma-2030” strategy
Read more: Approved action plan for implementing the “Pharma-2030” strategyThe Government of the Russian Federation has approved an action plan for implementing the strategy for the development of the pharmaceutical industry until 2030 (the “Pharma-2030” strategy), which was adopted in June 2023. The plan includes 40 specific measures related to financing new developments and expanding production, ensuring the quality of medicines, and improving regulatory…
-
CRPT: importers of dietary supplements turned out to be five times more than expected
Read more: CRPT: importers of dietary supplements turned out to be five times more than expectedCRPT “Honest Sign” shared the interim results of work in the field of dietary supplement labeling. In particular, the real volumes of the bioactive additives market were revealed: importers of these products turned out to be five times more than the state knew, and manufacturers – 41% more. This was told to GxP News by…
-
The State Duma is looking for executors of contracts for conducting expert research in the field of healthcare development
Read more: The State Duma is looking for executors of contracts for conducting expert research in the field of healthcare developmentSince February 2024, the State Duma of the Russian Federation has announced 17 auctions for expert and analytical research, the total starting price of which is 95 million rubles. Among them, four – worth 5.2 million rubles, 5.9 million rubles, 5.5 million rubles and about 5 million rubles – relate to the healthcare industry, they…
-
15 registration certificates of medicines have been withdrawn from the State Register
Read more: 15 registration certificates of medicines have been withdrawn from the State RegisterThe Ministry of Health of the Russian Federation has revoked registration certificates for 15 drugs based on applications from their owners. Of these, 13 belonged to JSC Pharmstandard-Tomskkhimpharm, the rest belonged to JSC Sanofi Russia. Information about this appeared on the GRLS website. Recalled drugs of JSC Pharmstandard-Tomskkhimpharm: “Ethyl alcohol” ((ethanol), LSR-008197/08 dated 10/16/2008); “Citramon…
-
The main news of the pharmaceutical industry in February 2024
Read more: The main news of the pharmaceutical industry in February 2024GxP News presents a digest of the main news of February 2024 in the pharmaceutical and healthcare industries. Market regulation Russian President Vladimir Putin delivered a message to the Federal Assembly. In particular, he announced the launch of new national projects. Several of them are relevant for the pharmaceutical industry – these are the national…